Australia has the world’s best researchers and health professionals, a world-class research infrastructure, and high standards for clinical trial conduct, which leads to quality, increased speed, and high confidence in the results. Note: This article was last updated in Oct 2024. They have quality research facilities, an efficient ethical and regulatory framework, a diverse participant […]

Read More →

Malaysia is one of the world’s most popular countries for coastal tourism, known for its culinary sensations, beautiful beaches, idyllic islands, and national parks. Conducting clinical trials in Malaysia offers a diverse patient population, well-established healthcare infrastructure, favorable regulatory environment, and cost-effective research opportunities. Note: This article was updated in May, 2023 Malaysia owns a large […]

Read More →

Vietnam, known for its tourism destination, is also a destination for clinical trials and research. With a sizeable population of 85 million, Vietnam offers a vast pool of participants, healthcare professionals, and strong doctor-patient relationships, which result in a greater retention rate. Clinical Trials in Vietnam In the last few years, Vietnam has been a […]

Read More →

The United States is the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies requires considering many factors and areas. Starting with some salient points on Clinical trials in the United States. In the first part of this series of articles on clinical trials in […]

Read More →

With a population of over 51.75 million people, South Korea offers a diverse patient population with a range of medical conditions, making it an ideal location for conducting clinical trials with a broad range of participants. Additionally, the country has a well-developed healthcare system and skilled workforce, making it an attractive location for clinical research. […]

Read More →

Health Canada (HC) reviews, evaluates, and approves applications for clinical trials using authorized therapeutic products in Canada. HC assesses clinical trial protocols to evaluate participant protection and safety; reviews drug quality; assures institutional ethics committee review; verifies principal investigator qualifications; and monitors and reviews adverse drug reactions. HC also approves the sale or importation of […]

Read More →

The best reasons to conduct clinical trials in any country include the availability of patients, clarity of regulatory processes, willing and qualified investigators, and sound infrastructure at a reasonable cost. This is what you get if you conduct clinical trials in Romania. Let’s see this in greater detail. Brief demography Romania is a sovereign state located in Southeastern […]

Read More →

Poland is regarded as one of the largest clinical trials markets in CEE/CIS. In a report in 2010, PriceWaterhouseCoopers (PwC) pointed out that with 469 new clinical trial registrations in 2009, Poland accounted for c. 2.5%-3.0% of the world market by registration volumes. Current status of clinical research in Poland The status of clinical research has […]

Read More →

The United States has consistently emerged as a leading site for clinical research. Half of the total clinical trials conducted worldwide are being conducted in the United States. Most of the research pharma companies prefer to perform their clinical trials in the United States due to the reasons such as well-established medical infrastructure, fast approval […]

Read More →

Trial managers worldwide have been focusing on specific regions for placing their clinical trials. So much so that about 60-70% of clinical trials globally are conducted in the USA and Europe alone. However, this is slated to change or should change, if one consults a recent white paper published by Frost & Sullivan. The white […]

Read More →